CY1118996T1 - Χρηση οιστετρολης ως αντισυλληπτικο επειγουσας καταστασης - Google Patents
Χρηση οιστετρολης ως αντισυλληπτικο επειγουσας καταστασηςInfo
- Publication number
- CY1118996T1 CY1118996T1 CY20171100646T CY171100646T CY1118996T1 CY 1118996 T1 CY1118996 T1 CY 1118996T1 CY 20171100646 T CY20171100646 T CY 20171100646T CY 171100646 T CY171100646 T CY 171100646T CY 1118996 T1 CY1118996 T1 CY 1118996T1
- Authority
- CY
- Cyprus
- Prior art keywords
- emergency
- ostetrol
- estestrol
- estatriene
- tetrahydroxylated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Abstract
Η παρούσα εφεύρεση σχετίζεται με μία νέα χρήση τετραϋδροξυλιωμένων οιστρογόνων όπως οιστετρόλη (1,3,5(10)-οιστατριεν-3, 15α, 16α, 17β-τετρόλη), συγκεκριμένα με μία μέθοδο επείγουσας αντισύλληψης. Η μέθοδος επείγουσας αντισύλληψης σύμφωνα με την εφεύρεση περιλαμβάνει την εκ του στόματος χορήγηση οιστετρόλης σε μία μόνη δόση εντός 120 ωρών από τη σεξουαλική επαφή.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161522480P | 2011-08-11 | 2011-08-11 | |
EP11177266 | 2011-08-11 | ||
PCT/EP2012/065572 WO2013021025A1 (en) | 2011-08-11 | 2012-08-09 | Use of estetrol as emergency contraceptive |
EP12753086.3A EP2741824B1 (en) | 2011-08-11 | 2012-08-09 | Use of estetrol as emergency contraceptive |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1118996T1 true CY1118996T1 (el) | 2018-01-10 |
Family
ID=47667911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20171100646T CY1118996T1 (el) | 2011-08-11 | 2017-06-20 | Χρηση οιστετρολης ως αντισυλληπτικο επειγουσας καταστασης |
Country Status (19)
Country | Link |
---|---|
US (3) | US9579329B2 (el) |
EP (1) | EP2741824B1 (el) |
AU (2) | AU2012293593B2 (el) |
BR (1) | BR112014003113A2 (el) |
CA (1) | CA2843951C (el) |
CY (1) | CY1118996T1 (el) |
DK (1) | DK2741824T3 (el) |
EA (1) | EA028780B1 (el) |
ES (1) | ES2631359T3 (el) |
HK (1) | HK1197027A1 (el) |
HR (1) | HRP20170797T1 (el) |
HU (1) | HUE033590T2 (el) |
LT (1) | LT2741824T (el) |
ME (1) | ME02723B (el) |
PL (1) | PL2741824T3 (el) |
PT (1) | PT2741824T (el) |
RS (1) | RS55974B1 (el) |
SI (1) | SI2741824T1 (el) |
WO (1) | WO2013021025A1 (el) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11053274B2 (en) | 2011-06-01 | 2021-07-06 | Estetra S.P.R.L. | Process for the production of estetrol intermediates |
CA2835979C (en) | 2011-06-01 | 2018-05-01 | Estetra S.A. | Process for the production of estetrol intermediates |
EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
PT2741824T (pt) * | 2011-08-11 | 2017-07-06 | Estetra Sprl | Utilização de estetrol como contracetivo de emergência |
TW201613576A (en) | 2014-06-26 | 2016-04-16 | Novartis Ag | Intermittent dosing of MDM2 inhibitor |
DK3310346T3 (da) | 2015-06-18 | 2021-05-25 | Estetra Sprl | Orodispersibel tablet indeholdende estetrol |
PL3310333T3 (pl) | 2015-06-18 | 2020-07-13 | Estetra Sprl | Ulegająca rozpadowi w jamie ustnej jednostka dawkowana zawierająca składnik estetrolowy |
MA44205B1 (fr) * | 2015-06-18 | 2021-04-30 | Estetra Sprl | Comprimé orodispersible comprenant estetrol |
GEP20217308B (en) | 2015-06-18 | 2021-10-25 | Estetra Sprl | Orodispersible dosage unit containing an estetrol component |
CA3178291A1 (en) | 2016-08-05 | 2018-04-12 | Estetra Srl | Method for the management of dysmenorrhea and menstrual pain |
TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
HU231240B1 (hu) | 2019-09-03 | 2022-04-28 | Richter Gedeon Nyrt. | Ipari eljárás nagytisztaságú ösztetrol hatóanyag előállítására |
US20230338355A1 (en) * | 2020-07-30 | 2023-10-26 | Acer Therapeutics Inc. | Nk antagonists for contraception |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2297273A1 (en) * | 2000-01-26 | 2001-07-26 | Michael D. Perelgut | 3 dimensional imaging of hard structure without the use of ionizing radiation |
ES2296943T3 (es) * | 2001-05-23 | 2008-05-01 | Pantarhei Bioscience B.V. | Sistema de administracion de un medicamento estrogeno tetrahidroxilado destinado a la contracepcion hormonal. |
CA2448273C (en) * | 2001-05-23 | 2010-06-29 | Christian Franz Holinka | Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception |
HU227198B1 (en) * | 2001-11-27 | 2010-10-28 | Richter Gedeon Nyrt | Pharmaceutical composition for emergency contraception containing levonorgestrel |
SI1562976T1 (sl) * | 2002-11-08 | 2010-08-31 | Pantarhei Bioscience Bv | Sinteza estetrola preko steroidov, izvedenih iz estrona |
JP2004235111A (ja) * | 2003-01-31 | 2004-08-19 | Ebara Corp | イオン伝導体及びその製造方法 |
PT2741824T (pt) * | 2011-08-11 | 2017-07-06 | Estetra Sprl | Utilização de estetrol como contracetivo de emergência |
EA032306B1 (ru) * | 2013-12-12 | 2019-05-31 | Донеста Байосайенс Б.В. | Орально распадающаяся твердая фармацевтическая единица дозирования, содержащая эстетрольный компонент, ее применение и способ получения |
-
2012
- 2012-08-09 PT PT127530863T patent/PT2741824T/pt unknown
- 2012-08-09 WO PCT/EP2012/065572 patent/WO2013021025A1/en active Application Filing
- 2012-08-09 CA CA2843951A patent/CA2843951C/en active Active
- 2012-08-09 LT LTEP12753086.3T patent/LT2741824T/lt unknown
- 2012-08-09 DK DK12753086.3T patent/DK2741824T3/en active
- 2012-08-09 PL PL12753086T patent/PL2741824T3/pl unknown
- 2012-08-09 ES ES12753086.3T patent/ES2631359T3/es active Active
- 2012-08-09 RS RS20170497A patent/RS55974B1/sr unknown
- 2012-08-09 HU HUE12753086A patent/HUE033590T2/hu unknown
- 2012-08-09 EA EA201400202A patent/EA028780B1/ru unknown
- 2012-08-09 US US14/238,310 patent/US9579329B2/en active Active
- 2012-08-09 AU AU2012293593A patent/AU2012293593B2/en active Active
- 2012-08-09 SI SI201230961A patent/SI2741824T1/sl unknown
- 2012-08-09 BR BR112014003113A patent/BR112014003113A2/pt not_active Application Discontinuation
- 2012-08-09 EP EP12753086.3A patent/EP2741824B1/en active Active
- 2012-08-09 ME MEP-2017-111A patent/ME02723B/me unknown
-
2014
- 2014-10-21 HK HK14110473.9A patent/HK1197027A1/xx unknown
-
2017
- 2017-01-13 US US15/405,968 patent/US20170196886A1/en not_active Abandoned
- 2017-05-26 HR HRP20170797TT patent/HRP20170797T1/hr unknown
- 2017-06-14 AU AU2017203991A patent/AU2017203991B2/en active Active
- 2017-06-20 CY CY20171100646T patent/CY1118996T1/el unknown
-
2021
- 2021-02-24 US US17/183,676 patent/US20210290636A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
HK1197027A1 (en) | 2015-01-02 |
RS55974B1 (sr) | 2017-09-29 |
US20210290636A1 (en) | 2021-09-23 |
DK2741824T3 (en) | 2017-07-10 |
AU2012293593A1 (en) | 2014-03-06 |
BR112014003113A2 (pt) | 2017-03-14 |
US20140200202A1 (en) | 2014-07-17 |
CA2843951C (en) | 2019-08-06 |
CA2843951A1 (en) | 2013-02-14 |
EA028780B1 (ru) | 2017-12-29 |
PT2741824T (pt) | 2017-07-06 |
US9579329B2 (en) | 2017-02-28 |
EP2741824B1 (en) | 2017-05-03 |
EP2741824A1 (en) | 2014-06-18 |
EA201400202A1 (ru) | 2014-06-30 |
US20170196886A1 (en) | 2017-07-13 |
AU2012293593A8 (en) | 2014-05-29 |
HRP20170797T1 (hr) | 2017-08-11 |
SI2741824T1 (sl) | 2017-06-30 |
HUE033590T2 (hu) | 2017-12-28 |
AU2017203991A1 (en) | 2017-07-06 |
ME02723B (me) | 2017-10-20 |
PL2741824T3 (pl) | 2018-03-30 |
AU2012293593B2 (en) | 2017-03-23 |
LT2741824T (lt) | 2017-06-26 |
AU2017203991B2 (en) | 2019-03-14 |
WO2013021025A1 (en) | 2013-02-14 |
ES2631359T3 (es) | 2017-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1118996T1 (el) | Χρηση οιστετρολης ως αντισυλληπτικο επειγουσας καταστασης | |
CY1121843T1 (el) | Σκευασματα ετανερσεπτης σταθεροποιημενα με ιοντα μαγνησιου | |
CY1121150T1 (el) | Νευροδραστικα 19-αλκοξυ-17-υποκατεστημενα στεροειδη, χρησιμα σε μεθοδους θεραπειας | |
CY1123953T1 (el) | Καθυστερημενης απελευθερωσης συνθεσεις λινακλοτιδης | |
CY1120805T1 (el) | Κρυσταλλικες μορφες αναστολεα προλυλο υδροξυλασης | |
CY1125061T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει δροσπιρενονη για χρηση ως ενα αντισυλληπτικο | |
CY1122648T1 (el) | Διαδικασια για την παρασκευη συνθεσεων που περιεχουν υαλουρονικο οξυ και υδροχλωρικη μεπιβακαϊνη | |
CY1119684T1 (el) | Αντι-ιικες ενωσεις | |
CY1115595T1 (el) | Αλατα ρασιγιλινης και φαρμακευτικη παρασκευη αυτων | |
CY1118813T1 (el) | Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων | |
CY1116987T1 (el) | Συμπυκνωμενα ιμιδαζολυλιμιδαζολια ως αντιϊικες ενωσεις | |
CR20180232A (es) | Macrociclos peptídicos contra acinetobacter baumannii | |
CR20160518A (es) | Compuestos para tratar atrofia muscular espinal | |
EA201391087A1 (ru) | Оральные лекарственные формы препарата тазоцитиниба с модифицированным высвобождением | |
DOP2011000402A (es) | Composicion farmaceutica para la anticoncepcion de emergencia | |
CY1116057T1 (el) | Παραγωγα κιναζολιν-4(3η)-ονης που χρησιμοποιουνται ως αναστολεις κινασης ρι3 | |
ECSP11011348A (es) | 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3 | |
CY1123056T1 (el) | Νεα μορφη χορηγησης της ρασεκαδοτριλης | |
CY1115043T1 (el) | Φαρμακευτικο σκευασμα | |
MX349119B (es) | Vacuna de virus de dengue inactivado. | |
CL2017003066A1 (es) | Composiciones de carbonato de calcio amorfo para administración mediante inhalación, sublingual o bucal | |
BR112012032008A2 (pt) | anticorpos s100a4 e usos terapêuticos do mesmo | |
GT201500235A (es) | Estra -1,3,5 (10) , 16- tetraeno -3-carboxamidas para la inhibicion de la 17b-hidroxiesteroide deshidrogenasa (akr1c3) | |
EA201591196A1 (ru) | Композиции и способы для трансдермальной доставки гормонов и других лекарственных средств | |
CY1115556T1 (el) | Φαρμακευτικη συνθεση για χορηγηση απο το στομα η οποια περιλαμβανει ετεξιλικη δαβιγατρανη |